Cardiomyopathy/Myocarditis
RSSArticles
-
Risk of Angioedema with Drug Therapy
Angioedema is an infrequent, but serious, adverse event from drug therapy. Drugs that affect the renin-angiotensin-aldosterone system have been linked to angioedema, but the relative frequency of this complication with these drugs is poorly understood. -
Risk of Bleeding with Warfarin Therapy for Atrial Fibrillation
This paper details the result of a population-based cohort study of all Ontario, Canada, residents older than 66 years of age who began warfarin therapy for atrial fibrillation over an 11-year period. -
Clinical Briefs in Primary Care Supplement
-
Current Drug Usage in Atrial Fibrillation
This paper reviews drug therapy in patients with atrial fibrillation in the Medicare population. The author extracted a 5% sample of Medicare beneficiaries who were enrolled in Medicare Part D. -
PCI Outcomes in Women vs Men
Percutaneous coronary intervention (PCI) is performed in more than 600,000 patients annually in the United States, and women make up approximately one-third of this population. -
Is There a Benefit to Cardiac Resynchronization Therapy in Patients with a Narrow QRS and Echocardiographic Dyssychrony?
-
Esmolol in Septic Shock
-
Are Eligible Patients in the Community Receiving ICDs?
-
Embolic Risk in Endocarditis
-
Colchicine in Acute Pericarditis